Comments
Loading...

Lumos Pharma

LUMONASDAQ
Logo brought to you by Benzinga Data
$3.97
0.277.30%
Last update: 10:02 AM
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$28.00
Lowest Price Target1
$7.00
Consensus Price Target1
$14.50

Lumos Pharma (NASDAQ:LUMO) Stock, Analyst Ratings, Price Targets, Forecasts

Lumos Pharma Inc has a consensus price target of $14.5 based on the ratings of 4 analysts. The high is $28 issued by HC Wainwright & Co. on March 20, 2024. The low is $7 issued by Jefferies on December 8, 2022. The 3 most-recent analyst ratings were released by Oppenheimer, HC Wainwright & Co., and HC Wainwright & Co. on August 2, 2024, March 20, 2024, and March 8, 2024, respectively. With an average price target of $23 between Oppenheimer, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 521.62% upside for Lumos Pharma Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
HC Wainwright & Co.
Cantor Fitzgerald
Jefferies

1calculated from analyst ratings

Analyst Ratings for Lumos Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Lumos Pharma (LUMO) stock?

A

The latest price target for Lumos Pharma (NASDAQ:LUMO) was reported by Oppenheimer on August 2, 2024. The analyst firm set a price target for $13.00 expecting LUMO to rise to within 12 months (a possible 227.46% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Lumos Pharma (LUMO)?

A

The latest analyst rating for Lumos Pharma (NASDAQ:LUMO) was provided by Oppenheimer, and Lumos Pharma maintained their outperform rating.

Q

When was the last upgrade for Lumos Pharma (LUMO)?

A

There is no last upgrade for Lumos Pharma

Q

When was the last downgrade for Lumos Pharma (LUMO)?

A

The last downgrade for Lumos Pharma Inc happened on December 8, 2022 when Jefferies changed their price target from $17 to $7 for Lumos Pharma Inc.

Q

When is the next analyst rating going to be posted or updated for Lumos Pharma (LUMO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lumos Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lumos Pharma was filed on August 2, 2024 so you should expect the next rating to be made available sometime around August 2, 2025.

Q

Is the Analyst Rating Lumos Pharma (LUMO) correct?

A

While ratings are subjective and will change, the latest Lumos Pharma (LUMO) rating was a maintained with a price target of $16.00 to $13.00. The current price Lumos Pharma (LUMO) is trading at is $3.97, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch